Navigation Links
Patients' Requests for Antidepressants can Influence Physician Evaluation of Depression

Patients who initiate a general discussion about the need for antidepressant medication with their primary care physician are more //likely to be thoroughly evaluated for depression than those who make a brand-specific request or no request, according to a new study in the December issue of Medical Care.

The study also found that general requests for antidepressants increased the likelihood that patients would be screened for the existence of suicidal acts or impulses.

The research was led by an investigator at the University of California, San Francisco (UCSF) in collaboration with researchers from the University of California, Davis and the University of Rochester.

In a previous study, the first controlled investigation of its kind, the research team had examined the clinical behavior of physicians faced with a patient request for antidepressant treatment. From this earlier study and others, the scientists found that patients' requests had a profound effect on physician prescribing habits regarding both major depression and the psychological condition known as adjustment disorder, which involves depression and anxiety in response to pain or a major event, such as illness or divorce, according to lead author Mitchell Feldman, MD, MPhil, professor of medicine at UCSF, and an internist at UCSF Medical Center.

"Our new research extends those findings by examining the impact of patient requests on the level of history-taking carried out by the physician and by exploring the association of history-taking with diagnostic accuracy as well as provision of acceptable initial care for depressed patients," he said.

The study was conducted with 18 "standardized patients" -- actors who are specifically trained to portray patients in medical education settings. Each "patient" portrayed a role involving one of two clinical presentations: major depression accompanied by carpal tunnel syndrome or an adjustment disorder a
'"/>




Page: 1 2 3

Related medicine news :

1. Painkillers Do Not Shorten Dying Patients Lives
2. Hemochromatosis Patients Blood is Safe
3. AIDS Funding Grants Dependant on Tracking Patients Names Efficiently
4. Doctors Response To Patients Religious Beliefs Can Vary
5. Queensland Health Holding Back Dental Patients HIV Results
6. New Genetic Test Predicts Eye-Cancer Patients Futures
7. Canadian Street Prostitutes Requests Protection
8. New Zealand Requests Details from Britain about ‘Black Sheep
9. Cyberkinetics Requests FDA to Sell Nerve Growth Stimulation System
10. FDA Requests Label Change for All Sleep Disorder Drug Products
11. Antidepressants come in handy for patients on treatment for hepatitis, cancers and multiple sclerosis
Post Your Comments:
(Date:12/5/2009)NEW ORLEANS, Dec. 5 Leukemia and myeloproliferative disorders are serious and often deadly blood cancers. Research presented today at the 51st Annual Meeting of the American Society of Hematology int
(Date:12/5/2009)Research debunks the ,something,s wrong with being single, myth , , SATURDAY, Dec. 5 (HealthDay News) -- Pity the poor single people who pass their 40th birthday without ever tying the knot, s
(Date:12/5/2009)AVIVA today announced the launch of International Solutions, an innovative new international private medical insurance plan which follows the acclaimed modular design of its UK equivalent. In addition
(Date:12/5/2009)Wind Turbines are popping up in the most unusual places, and to do everything from growing mushrooms, making wine to keeping prisoners in jail! , (PRWEB) December 5, 2009 -- W
(Date:12/4/2009)NEW YORK, Dec. 4 Care Investment Trust Inc. (NYSE: CRE ) ("Care" or the "Company") today announced that its Board of Directors has declared a dividend of $0.17 per share of common stock. The div
Breaking Medicine News(10 mins):Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 2Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 3Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 4Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 5Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 6Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 7Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 8Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 9Health News:Never Married, Over 40, Well-Adjusted 2Health News:Never Married, Over 40, Well-Adjusted 3Health News:AVIVA's Private Health Insurance Products Solutions Go International 2Health News:Distributor Announces New Applications for Wind Turbines 2Health News:Distributor Announces New Applications for Wind Turbines 3Health News:Care Investment Trust Inc. Declares Quarterly Dividend of $0.17 Per Share 2
...onor Hospital Excellence, KALAMAZOO, Mich., Sept....ed the Governor,s Award for Improving Patient,Safe... addition, 29,Critical Access hospitals statewide ...d(s) in partnership with,MPRO, Michigan,s Quality ...
...0, 2007) New evidenced-based guidelines from the ...end against the use of low-dose computed tomograph... Published as a supplement to the September issue ...nts, including those who are considered at high ri...
...be a sport where the,drivers are sitting while per... has to be as intense as any professional athlete....d to be mentally tough, as well,physically fit, so.../WebNR.aspx?story=33827 Oliver Gavin is four-tim...
...ascular surgery technique pioneered at UT Southwes...om the thigh to repair the aorta does not create b...ajority of patients, researchers report. , Vascul...aged aortas, the largest artery in the body, is ty...
...ains, olive oil lived 4 years longer, study found ...onsuming what,s known as a Mediterranean diet -- o...e oil -- may help Alzheimer,s patients live longer...ows on earlier work by the same team that suggests...
...rs determine out-of-pocket health care costs, CAM...troduced a new tool to help consumers compare heal...ir needs. The Plan Cost Advisor is available,to co... Customer Relationship Management.,"This is especi...
Other Medicine News:Health News:Michigan Hospitals Receive Governor's Award 2Health News:Michigan Hospitals Receive Governor's Award 3Health News:New lung cancer guidelines oppose general CT screening 2Health News:New lung cancer guidelines oppose general CT screening 3Health News:New lung cancer guidelines oppose general CT screening 4Health News:Natural aorta grafts have few side effects for infection-prone patients 2Health News:Mediterranean Diet May Boost Alzheimer's Survival 2Health News:Mediterranean Diet May Boost Alzheimer's Survival 3Health News:Mediterranean Diet May Boost Alzheimer's Survival 4Health News:Highmark Blue Shield Introduces New Health Plan Comparison Tool for Consumers 2
(Date:12/4/2009)SAN DIEGO, Calif., Dec. 4 Suneva Medical, a privately-held aesthetic medical device company, today announced the appointment of Philip Ranker as Vice President and Chief Financial Officer. In this r
(Date:12/4/2009)BETHESDA, Md., Dec. 4 Drs. Neal Shore and E. David Crawford presented results for prostate-specific antigen (PSA) recurrence from the additional analysis of secondary end points of biochemical recurr
(Date:12/3/2009)ACTON, Mass., Dec. 3 Allen Medical Systems, a subsidiary of Hill-Rom Holdings, Inc. (NYSE: HRC ), today announced the launch of its new Allen Amatech(TM) OEM (Original Equipment Manufacturer) busin
Breaking Medicine Technology:Suneva Medical Announces Corporate Developments Including Appointment of Philip Ranker as Chief Financial Officer 2Suneva Medical Announces Corporate Developments Including Appointment of Philip Ranker as Chief Financial Officer 3Suneva Medical Announces Corporate Developments Including Appointment of Philip Ranker as Chief Financial Officer 4Degarelix (FIRMAGON(R)) vs Leuprolide (Lupron Depot(R)) in Patients With Advanced Prostate Cancer: Further Analysis From a Phase III Pivotal Trial 2Degarelix (FIRMAGON(R)) vs Leuprolide (Lupron Depot(R)) in Patients With Advanced Prostate Cancer: Further Analysis From a Phase III Pivotal Trial 3Degarelix (FIRMAGON(R)) vs Leuprolide (Lupron Depot(R)) in Patients With Advanced Prostate Cancer: Further Analysis From a Phase III Pivotal Trial 4Allen Medical Systems Announces the Launch of New Allen Amatech(TM) OEM Website 2Many Hospitals Are Not Ready for H1N1 3A Nurse Survey Shows Deficiencies in Hospital Swine Flu Readiness 55369 1Many Hospitals Are Not Ready for H1N1 3A Nurse Survey Shows Deficiencies in Hospital Swine Flu Readiness 55369 2Many Hospitals Are Not Ready for H1N1 3A Nurse Survey Shows Deficiencies in Hospital Swine Flu Readiness 55369 3Top Newport Beach Plastic Surgeon Appointed President of Orange County Society of Plastic Surgeons 55366 1Top Newport Beach Plastic Surgeon Appointed President of Orange County Society of Plastic Surgeons 55366 2eMindful Offers Employers Complete Set of Wellness Tools Partnership with Online Health Coaching Service Rounds Out Health Package 55361 1eMindful Offers Employers Complete Set of Wellness Tools Partnership with Online Health Coaching Service Rounds Out Health Package 55361 2eMindful Offers Employers Complete Set of Wellness Tools Partnership with Online Health Coaching Service Rounds Out Health Package 55361 3
...sponse Network (LRN), the national laboratory syst...ergencies, will mark its first decade at its natio..., , Founded in 1999 by the Association of Public ...e Control and Prevention (CDC) and the Federal Bur...ioterrorism, the Laboratory Response Network has e...
.... (Nasdaq: ARNA ) today announced it will hold a...2009 at 8:30 a.m. Eastern Time (5:30 a.m. Pacific ...vioral modification and Lorcaserin for Overweight ...trials evaluating the safety and efficacy of lorca...and Chief Executive Officer, Dominic P. Behan, Ph....
Other Medicine Technology:Nation's Laboratory Response Network Marks First Decade of Protecting Public Health 2Arena Pharmaceuticals to Host Conference Call and Webcast on Monday, March 30, 2009 to Discuss Lorcaserin Pivotal Phase 3 Obesity Trial Results 2Arena Pharmaceuticals to Host Conference Call and Webcast on Monday, March 30, 2009 to Discuss Lorcaserin Pivotal Phase 3 Obesity Trial Results 3
5F Infiniti
Softtouch
CT Micro Stereotactic System
Tapered Tefcor Movable Core Wire Guides
Medicine Products: